Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
Heterologous vaccination regimens for COVID-19 could be useful for example if there is a shortage of one vaccine type. Here, Spencer et al. show that heterologous vaccination with a self-amplifying RNA vaccine and an adenoviral vectored vaccine performs at least as well as the homologous vaccination...
Enregistré dans:
Auteurs principaux: | Alexandra J. Spencer, Paul F. McKay, Sandra Belij-Rammerstorfer, Marta Ulaszewska, Cameron D. Bissett, Kai Hu, Karnyart Samnuan, Anna K. Blakney, Daniel Wright, Hannah R. Sharpe, Ciaran Gilbride, Adam Truby, Elizabeth R. Allen, Sarah C. Gilbert, Robin J. Shattock, Teresa Lambe |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b9635c93599e4d14abcf385c2298f08d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
par: Paul F. McKay, et autres
Publié: (2020) -
Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases
par: Damien van de Berg, et autres
Publié: (2021) -
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
par: Samir Andrade Mendonça, et autres
Publié: (2021) -
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
par: César López-Camacho, et autres
Publié: (2018) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
par: L. V. Cherenova, et autres
Publié: (2017)